Journal of Bodywork and Movement Therapies
Volume 2, Issue 3 , Pages 168-174 , July 1998

Multiple sclerosis patients benefit from massage therapy

Received February 1998 ,Accepted April 1998.

References 

  1. Becker CC, Gidal BE, Fleming JO. Immunotherapy in multiple sclerosis: Part 2. American Journal of Health-System Pharmacy. 1995;52:2105–2120
  2. Brown TA, Cash TF, Mikulka PJ. Attitudinal body image assessment: factor analyses of the Body-Self Relations Questionnaire. Journal of Personality Assessments. 1990;55:135–144
  3. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Measurement of health-related quality of life in multiple sclerosis. Canadian Journal of Neurological Sciences. 1996;23:99–103
  4. Chia YW, Gill KP, Jameson JS, Forti AD, Henry MM, Swash M, et al. Paradoxical puborectalis contraction is a feature of constipation in patients with multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 1996;60:31–35
  5. Fawcett J, Sidney JS, Hanson MJ, Riley-Lawless K. Use of alternative health therapies by people with multiple sclerosis: an exploratory study. Holistic Nursing Practice. 1994;8:36–42
  6. Field T, Morrow C, Valdeon C, Larson S, Kuhn C, Schanberg S. Massage therapy reduces anxiety in child and adolescent psychiatric patients. Journal of the American Academy of Child and Adolescent Psychiatry. 1992;31:125–131
  7. Field T, Gizzle N, Scafidi F, Schanberg S. Massage and relaxation therapies' effects on depressed adolescent mothers. Adolescence. 1996;31:903–911
  8. (in press) Field T, Henteleff T, Hernandez-Reif M, Martinez E, Kunjana M, Kuhn C, et al. Asthmatic children have improved pulmonary function after massage treatment. Journal of Pediatrics. 1997;
  9. Field T, Hernandez-Reif M, LaGreca A, Shaw K, Schanberg S, Kuhn C. Massage therapy lowers blood glucose levels in children with diabetes. Diabetes Spectrum. 1997;10:28–30
  10. Field T, Hernandez-Reif M, Seligman S, et al. Juvenile rheumatoid arthritis benefits from massage therapy. Journal of Pediatric Psychology. 1997;22:607–617
  11. Field T, Sunshine W, Hernandez-Reif M, Quinitino O, Schanberg S, Kuhn C, et al. Massage therapy effects on depression and somatic symptoms in chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome. 1997;3:43–51
  12. (in press) Field T, Schanberg S, Kuhn C, et al. Bulimic adolescents benefit from massage therapy. Adolescence. 1998;
  13. Gilchrist AC, Creed FH. Depression, cognitive impairment and social stress in multiple sclerosis. Journal of Psychosomatic Research. 1994;38:193–201
  14. Goodkin DE, Cookfair D, Wende K, et al. Inter- and intra-rater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Neurology. 1992;42:859–863
  15. Hafler DA, Weiner HL. MS: A central nervous system and systemic autoimmune disease. Immunology Today. 1989;10:104–107
  16. Hauser SL, Dawson DM, Lehrich JR, et al. Intensive immunosuppression in progressive multiple sclerosis. New England Journal of Medicine. 1983;308:173–180
  17. Hermann BP, Vickrey B, Hays RD, et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Research. 1996;25:113–118
  18. (in review) Hernandez-Reif M, Field T, Krasnegor J, Theakston H, Burman I. Lower back pain is reduced following massage and relaxation therapies. 1997;
  19. (Suppl) Klarskov P, Heely E, Nyholdt I, Rottensten K, Nordenbo A. Biofeedback treatment of bladder dysfunction in multiple sclerosis. A randomized trial. Scandinavian H of Urology & Nephrology. 1994;157:61–65
  20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  21. LaRiccia PJ, Katz RH, Peters JW, Atkinson GW, Weiss T. Biofeedback and hypnosis in weaning from mechanical ventilators. Chest. 1985;87:267–269
  22. Lindsey JW, Hodgkinson S, Mehta R, et al. Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis. Neurology. 1994;44:413–419
  23. Lublin FD, Whitaker JN, Eidelman BH, Miller AE, Arnason BG, Burks JS. In: Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology. 46:1996;p. 12–18
  24. McGurie BL. The effects of imagery on attitudes and moods in multiple sclerosis. Alternative Therapies in Health and Medicine. 1996;2:59–75
  25. McNair DM, Lorr M, Droppleman LF. POMS — Profile of Mood States. Baltimore: Educational and Industrial Testing Service; 1971;
  26. Mitchell G. Update on multiple sclerosis therapy. Medical Clinics of North America. 1993;77:231–249
  27. Morrison W, Nelson J. Environmental triggers in multiple sclerosis. Fact or fallacy? Axone. 1994;16:23–26
  28. Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurology. 1996;46:552–554
  29. Pugatch D, Haskell D, McNair DM. Predictors and patterns of change associated with the course of time-limited psychotherapy (mimeo report). 1969;
  30. Part 2 Rose AS, Kuzma JW, Kurtzke JF, Sibley WA, Tourtellotte WW. Cooperative study in the evaluation of therapy in multiple sclerosis; ACTH vs placebo in acute exacerbations: preliminary report. Neurology. 1968;18:6
  31. Rosenberg M. Society and the Adolescent Self-Image. San Diego, CA: Princeton University Press; 1965;
  32. Sandyk R. Reversal of acute parkinson syndrome associated with multiple sclerosis by application of weak electromagnetic fields. International Journal of Neuroscience. 1996;86:33–45
  33. Spielberger CD. Anxiety as an emotional state. In: Spielberger CD editors. Anxiety: Current Trends in Theory and Research. Princeton, NJ: Academic Press; 1972;
  34. Spielberger CD, Gorusch RC, Lushene RE. The State Trait Anxiety Inventory. New York: Consulting, Psychologists Press; 1970;
  35. Steinberger A. Specific irritability of acupuncture points as an early symptom of multiple sclerosis. American Journal of Chinese Medicine. 1986;14:175–178
  36. Sunshine W, Field T, Quintino O, Fiero K, Kuhn C, Burman I, et al. Fibromyalgia benefits from massage therapy and transcutaneous electrial stimulation. Journal of Clinical Rheumatology. 1996;2:18–22
  37. Tulman L, Fawcett J, McEvoy MD. Development of the Inventory of Functional Status-Cancer. Cancer Nursing. 1991;14:254–260
  38. Woolf K. Intravenous methylprednisolone for exacerbations in multiple sclerosis. MEDSURG Nursing. 1995;4:207–210

PII: S1360-8592(98)80009-0

Journal of Bodywork and Movement Therapies
Volume 2, Issue 3 , Pages 168-174 , July 1998

Article Tools